St.-Blaise, Switzerland

Claudio Facchinetti

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Philip Morris Products S.a.. Active years: 2019.


% Patents Active = 100.0


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudio Facchinetti: Innovator in Protein Expression

Introduction

Claudio Facchinetti is a notable inventor based in St.-Blaise, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of protein expression in plants. His innovative work has the potential to revolutionize the production of recombinant polypeptides.

Latest Patents

Facchinetti holds a patent related to protein expression in plants. The patent focuses on the large-scale production of recombinant polypeptides in whole plants. This invention utilizes a preselected combination of varieties and strains, which may include improvements to transient expression-based methods. This approach enables the economical production of large quantities of heterologous polypeptides in a short period of time. He has 1 patent to his name.

Career Highlights

Claudio Facchinetti is associated with Philip Morris Products S.A., where he applies his expertise in biotechnology. His work at the company highlights his commitment to advancing scientific research and innovation in the field.

Collaborations

Facchinetti collaborates with talented individuals such as Julien Beuchat and Prisca Campanoni. These partnerships enhance the research and development efforts in his area of expertise.

Conclusion

Claudio Facchinetti is a pioneering inventor whose work in protein expression in plants holds great promise for the future of biotechnology. His contributions are paving the way for more efficient and cost-effective methods of producing essential proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…